Obstetrics & Gynecology Science

Gynecologic Oncology
Incidence and predictive factors for recurrent clear cell ovarian carcinoma: results from a single center in Thailand: Wikanda Hemman, Athithan Rattanaburi; Obstet Gynecol Sci. 2022;65(2):188-196. Published online February 23, 2022; DOI: https://doi.org/10.5468/ogs.21313
Web of Science 2 Crossref 2; Full text PubReader ePub PDF Supplementary Material

Prognostic significance of tumor laterality in advanced ovarian cancer: Yuki Yamada, Seiji Mabuchi, Naoki Kawahara, Ryuji Kawaguchi; Obstet Gynecol Sci. 2021;64(6):524-531. Published online September 14, 2021; DOI: https://doi.org/10.5468/ogs.21176
Web of Science 4 Crossref 5; Full text PubReader ePub PDF Supplementary Material

Impact of lymphadenectomy on the treatment of endometrial cancer using data from the JSOG cancer registry: Keiko Saotome, Wataru Yamagami, Hiroko Machida, Yasuhiko Ebina, Yoichi Kobayashi, Tsutomu Tabata, Masanori Kaneuchi, Satoru Nagase, Takayuki Enomoto, Daisuke Aoki, Mikio Mikami; Obstet Gynecol Sci. 2021;64(1):80-89. Published online November 27, 2020; DOI: https://doi.org/10.5468/ogs.20186
Web of Science 5 Crossref 5; Full text PubReader ePub PDF

Prognostic value of programmed cell death ligand-1 expression in ovarian cancer: an updated meta-analysis: Jinlan Piao, Hyun Ji Lim, Maria Lee; Obstet Gynecol Sci. 2020;63(3):346-356. Published online March 24, 2020; DOI: https://doi.org/10.5468/ogs.2020.63.3.346
Web of Science 9 Crossref 11; Full text PubReader ePub PDF

Prognostic significance of pretreatment lymphocyte percentage and age at diagnosis in patients with locally advanced cervical cancer treated with definite radiotherapy: Myung-Hwa Jeong, Hyungjoo Kim, Tae-Hun Kim, Moon-Hong Kim, Beob-Jong Kim, Sang-Young Ryu; Obstet Gynecol Sci. 2019;62(1):35-45. Published online December 3, 2018; DOI: https://doi.org/10.5468/ogs.2019.62.1.35
Crossref 10; Full text PubReader ePub PDF

Clinicopathologic characteristics of ovarian clear cell carcinoma in the background of endometrioma: a surveillance strategy for an early detection of malignant transformation in patients with asymptomatic endometrioma: Joo-Hyuk Son, Seokyoung Yoon, Seokyung Kim, Tae-Wook Kong, Jiheum Paek, Suk-Joon Chang, Hee-Sug Ryu; Obstet Gynecol Sci. 2019;62(1):27-34. Published online December 3, 2018; DOI: https://doi.org/10.5468/ogs.2019.62.1.27
Crossref 8; Full text PubReader ePub PDF

Gynecologic Oncology
Effect of tibolone on the survival of early stage cervical adenocarcinoma patients: Seung-Ho Lee, Yoon-Jin Cho, Kyung-Joo Cho, Mee-Hyang Ko, Sun-Young Jung, Seung-Joo Chon, So-Yi Lim, Kwang-Beom Lee; Obstet Gynecol Sci. 2018;61(5):584-589. Published online August 7, 2018; DOI: https://doi.org/10.5468/ogs.2018.61.5.584
Crossref 3; Full text PubReader PDF

Gynecologic Oncology
Clinical characteristics and outcomes of placental site trophoblastic tumor: experience of single institution in Korea: Hye-joo Lee, Wonkyo Shin, Yun Jeong Jang, Chel Hun Choi, Jeong-Won Lee, Duk-Soo Bae, Byoung-Gie Kim; Obstet Gynecol Sci. 2018;61(3):319-327. Published online April 27, 2018; DOI: https://doi.org/10.5468/ogs.2018.61.3.319
Crossref 8; Full text PubReader PDF

Pretreatment neutrophil-to-lymphocyte ratio and its dynamic change during neoadjuvant chemotherapy as poor prognostic factors in advanced ovarian cancer: Yun-Ji Kim, Inha Lee, Young Shin Chung, EunJi Nam, Sunghoon Kim, Sang-Wun Kim, Young Tae Kim, Jung-Yun Lee; Obstet Gynecol Sci. 2018;61(2):227-234. Published online February 5, 2018; DOI: https://doi.org/10.5468/ogs.2018.61.2.227
Crossref 18; Full text PubReader PDF

Prognostic assessment of sarcomatous histologic subtypes of ovarian carcinosarcoma: Hyun Jin Kim, Hyun-Mi Lee, Mi Kyung Kim, Yoo-Kyung Lee, In-Ho Lee, Ki-Heon Lee, Hyesun Kim; Obstet Gynecol Sci. 2017;60(4):350-356. Published online July 14, 2017; DOI: https://doi.org/10.5468/ogs.2017.60.4.350
Crossref 8; Full text PubReader PDF

The influence of number of high risk factors on clinical outcomes in patients with early-stage cervical cancer after radical hysterectomy and adjuvant chemoradiation: Soyi Lim, Seok-Ho Lee, Kwang Beom Lee, Chan-Yong Park; Obstet Gynecol Sci. 2016;59(3):184-191. Published online May 13, 2016; DOI: https://doi.org/10.5468/ogs.2016.59.3.184
Crossref 5; Full text PubReader PDF

Human papillomavirus 18 as a poor prognostic factor in stage I-IIA cervical cancer following primary surgical treatment: Sun-Hye Yang, Su-Kyoung Kong, Seung-Ho Lee, So-Yi Lim, Chan-Yong Park; Obstet Gynecol Sci. 2014;57(6):492-500. Published online November 20, 2014; DOI: https://doi.org/10.5468/ogs.2014.57.6.492
Crossref 15; Full text PubReader PDF

Thrombocytosis as a prognostic marker in stage III and IV serous ovarian cancer: Antonia Digklia, Ioannis A. Voutsadakis; Obstet Gynecol Sci. 2014;57(6):457-463. Published online November 20, 2014; DOI: https://doi.org/10.5468/ogs.2014.57.6.457
Crossref 18; Full text PubReader PDF

Gynecologic Oncology
Impact of body mass index on the prognosis of Korean women with endometrioid adenocarcinoma of the uterus: A cohort study: Jeong-Yeol Park, Jae-Hyun Cho, Jin-Young Min, Dae-Yeon Kim, Jong-Hyeok Kim, Yong-Man Kim, Young-Tak Kim, Joo-Hyun Nam; Obstet Gynecol Sci. 2014;57(2):115-120. Published online March 15, 2014; DOI: https://doi.org/10.5468/ogs.2014.57.2.115
Crossref 3; Full text PubReader PDF

Gynecologic Oncology
Effect of human papillomavirus genotype on severity and prognosis of cervical intraepithelial neoplasia: Chun-Hoe Ku, Seung-Ho Lee, Soon-Pyo Lee; Obstet Gynecol Sci. 2014;57(1):37-43. Published online January 16, 2014; DOI: https://doi.org/10.5468/ogs.2014.57.1.37
Crossref 5; Full text PubReader PDF

Search